Abstract
The tumor suppressor gene p16 (CDKN2/MTS-1/INK4A) is an important component of the cell cycle and inactivation of the gene has been found in a variety of human cancers. In order to investigate the role of p16 gene in the tumorigenesis of hepatocellular carcinoma (HCC), 48 cases of HCC were analysed for p16 alterations by: methylation-specific PCR (MSP) to determine the methylation status of the p16 promoter region; comparative multiplex PCR to detect homozygous deletion; PCR – SSCP and DNA sequencing analysis to identify mutation of the p16 gene. We found high frequency of hypermethylation of the 5′ CpG island of the p16 gene in 30 of 48 cases (62.5%) of HCC tumors. Moreover, homozygous deletion at p16 region were present in five of 48 cases (10.4%); and missense mutation were detected in three of 48 cases (6.3%). The overall frequency of p16 alterations, including homozygous deletion, mutation and hypermethylation, in HCC tumors was 70.8% (34 of 48 cases). These findings suggest that: (a) the inactivation of the p16 is a frequent event in HCC; (b) the p16 gene is inactivated by multiple mechanisms including homozygous deletion, promoter hypermethylation and point mutation; (c) the most common somatic alteration of the p16 gene in HCC is de novo hypermethylation of the 5′ CpG island; and (d) in contrast to other studies, high frequency of genomic alterations are not uncommon in the 9p21 of the p16 gene. Our results strongly suggest that the p16 gene plays an important role in the pathogenesis of HCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. . 1998 Adv. Cancer Res. 72: 141–196.
Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu D-B and Leggett B. . 1997 Hepatology 25: 593–597.
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky D. . 1995 Nature Genet. 11: 210–212.
Cairns P, Tokino K, Eby Y and Sidransky D. . 1994 Cancer Res. 54: 1422–1424.
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE. . 1994 Nature Genet. 8: 27–32.
Chaubert P, Gayer R, Zimmermann A, Fontolliet C, Stamm B, Bosman F and Shaw P. . 1997 Hepatology 25: 1376–1381.
Gerber MA, Shieh YSC, Shim KS, Thung SN, Demetris AJ, Schwartz M, Akyol G and Dash S. . 1992 Am. J. Pathol. 141: 1271–1277.
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. . 1995 Cancer Res. 55: 4525–4530.
Hong Kong Hospital Authority. . 1998 Cancer incidence and mortality in Hong Kong 1993–94. Hong Kong Cancer Report.
Hui A-M, Sakamoto M, Kanai Y, Ino Y, Gotoh M, Yokota J and Hirohashi S. . 1996 Hepatology 24: 575–579.
Hussussian CJ, Struewing JP, Golstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC. . 1994 Nature Genet. 8: 15–21.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stochert E, Day RS, Johnson BE and Skolnick MH. . 1994 Science 264: 436–440.
Kita R, Nishida N, Fukuda Y, Azechi H, Matsuoka Y, Komeda T, Sando T, Nakao K and Ishizaki K. . 1996 Int. J. Cancer 67: 176–180.
Marx JA. . 1994 Science 264: 1846.
Merlo A, Herman JG, Mao L, Lee DJ, Gabreilson E, Burger PC, Baylin SB and Sidransky D. . 1995 Nature Med. 1: 686–692.
Mischiati C, Fiorentino D and Gambari R. . 1993 Bioteshuiqere 15: 146–151.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. . 1994 Nature 368: 753–756.
Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. . 1994 Proc. Natl. Acad. Sci. USA 91: 11045–11049.
Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwara M, Yue X, Beach DH, Yokota J and Harris C. . 1995 Cancer Res. 55: 1448–1451.
Pomerantz J, Schreiber-Agus N, Liegeois JN, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.
Qin L, Tang Z, Liu K, Ye S, He B and Zhou G. . 1996 Oncol. Reports 3: 405–408.
Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D. . 1996 Cancer Res. 56: 3630–3633.
Serrano M, Gomz-Lahoz E, DePinho RA, Berch D and Bar-Sagi D. . 1995 Science 267: 249–252.
Serrano M, Hannon GJ and Beach D. . 1993 Nature 366: 704–707.
Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K and Nakano M. . 1993 Cancer 72: 683–688.
Weising K, Beyermann B, Ramser J and Kahl G. . 1991 Electrophoresis 12: 159–169.
Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.
Acknowledgements
This research is supported by the Research Grant Committee, Hong Kong (Project ID: 2140122). We are grateful to Professor CC Liew, Director of the Molecular Diagnostic Center of the University of Toronto, Canada for his advice and positive critical review of the manuscript. We also thank Pui Chung Wong for proof reading and typing our manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liew, C., Li, HM., Lo, KW. et al. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 18, 789–795 (1999). https://doi.org/10.1038/sj.onc.1202359
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202359
Keywords
This article is cited by
-
Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines
Journal of Gastrointestinal Cancer (2021)
-
Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma
Cell Death & Disease (2017)
-
Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics
Hepatology International (2017)
-
Exploration of liver cancer genomes
Nature Reviews Gastroenterology & Hepatology (2014)
-
Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma
Journal of Gastroenterology (2013)